Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice
Wenchao Zhang(Jiangsu University), Diana M. Shih(University of California, Los Angeles), Susanne B. Nicholas(University of California, Los Angeles), Matteo Pellegrini(Institute of Molecular and Cell Biology), Clara E. Magyar(University of California, Los Angeles), Aika Miikeda(University of California, Los Angeles), Zhiqiang Zhou(University of California, Los Angeles), Aldons J. Lusis(ABT Molecular Imaging (United States)), Zeneng Wang(Cleveland Clinic), Stanley L. Hazen(Cleveland Clinic), Jonathan E. Zuckerman(University of California, Los Angeles), Karolina Elżbieta Kaczor‐Urbanowicz(QB3), Xun Jia(Cleveland Clinic Lerner College of Medicine), Fangfei Guo(University of California, Los Angeles), Sarada Charugundla(University of California, Los Angeles)
Cited by 146
Related Papers
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
Multi-omics approaches to disease
|Genome biology|2017|2.7k
Gut Microbiota in Cardiovascular Health and Disease
|Circulation Research|2017|1.6k
Gut Microbiota and Cardiovascular Disease
|Circulation Research|2020|1k
Tissue-specific expression and regulation of sexually dimorphic genes in mice
|Genome Research|2006|936